Commercial
Advanced Search
Type
  
Name
  
MPPolicyNumber
  
MPDispTitle
  
Policy Category
  
Title
  
MPPolicyPageName
  
ID
  
MPTitle
  
MPPolicyNumberwithoutversion
  
MPattachmentdataPub
5e08d9ea-1b0b-41e3-bdb1-b89be8d6a671.aspx
  
07.00.14i​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Low-LevelLaserTherapy07.00.14iMedicine (07)​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Low-Level Laser Therapy5e08d9ea-1b0b-41e3-bdb1-b89be8d6a6718055​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Low-Level Laser Therapy07.00.14
7542a735-fbef-48da-88c4-0ad3ed464755.aspx
  
08.00.62rAbatacept(Orencia®)forInjectionforIntravenousUse08.00.62rPharmacy (08)Abatacept (Orencia®) for Injection for Intravenous Use7542a735-fbef-48da-88c4-0ad3ed4647557772Abatacept (Orencia®) for Injection for Intravenous Use08.00.62
{"7773": {"Id":7773,"MPAttachmentLetter":"A","Title":"ICD-10 CODES AND NARRATIVES","MPPolicyAttachmentInternalSourceId":9995,"PolicyAttachmentPageName":"1e68ee86-f58f-43a3-b74c-f9f333d4ea06"},}
faf07099-5fa8-46ac-83e5-d19e25f4a190.aspx
  
11.00.16kAblationofLungTumors11.00.16kSurgery (11)Ablation of Lung Tumorsfaf07099-5fa8-46ac-83e5-d19e25f4a1908048Ablation of Lung Tumors11.00.16
cbf53801-3c3f-4dda-baab-7f1cb85bedc5.aspx
  
12.00.01iAcupuncture12.00.01iMiscellaneous (12)Acupuncturecbf53801-3c3f-4dda-baab-7f1cb85bedc58111Acupuncture12.00.01
{"8112": {"Id":8112,"MPAttachmentLetter":"A","Title":"ICD-10 CM Codes Eligible to be Reported for Acupuncture","MPPolicyAttachmentInternalSourceId":10302,"PolicyAttachmentPageName":"cc063bb2-cfd1-47da-8413-3775023fa7ec"},}
93be4241-0013-4435-bfba-3538e798d323.aspx
  
12.04.04bAcuteCareFacilityInpatientTransfers12.04.04bMiscellaneous (12)Acute Care Facility Inpatient Transfers93be4241-0013-4435-bfba-3538e798d3237647Acute Care Facility Inpatient Transfers12.04.04
f7a4114a-79c9-40bf-a707-b9706da6b983.aspx
  
08.02.21ADAMTS13,recombinant-krhn(Adzynma)08.02.21Pharmacy (08)ADAMTS13, recombinant-krhn (Adzynma)f7a4114a-79c9-40bf-a707-b9706da6b9837389ADAMTS13, recombinant-krhn (Adzynma)08.02.21
8ce8d9c2-c688-4751-a9e2-267eae6d0493.aspx
  
08.01.11jAdo-TrastuzumabEmtansine(Kadcyla®)08.01.11jPharmacy (08)Ado-Trastuzumab Emtansine (Kadcyla®)8ce8d9c2-c688-4751-a9e2-267eae6d04937851Ado-Trastuzumab Emtansine (Kadcyla®)08.01.11
6df88e0d-d8e3-4162-93fb-7747badd3e30.aspx
  
08.02.32aAfamitresgeneautoleucel(Tecelra®)08.02.32aPharmacy (08)Afamitresgene autoleucel (Tecelra®)6df88e0d-d8e3-4162-93fb-7747badd3e307264Afamitresgene autoleucel (Tecelra®)08.02.32
83ba0b83-419f-4e0a-b0e9-bea9d2e580fe.aspx
  
08.00.69dAgalsidasebeta(Fabrazyme®)andpegunigalsidasealfa-iwxj(Elfabrio)08.00.69dPharmacy (08)Agalsidase beta (Fabrazyme®) and pegunigalsidase alfa-iwxj (Elfabrio) 83ba0b83-419f-4e0a-b0e9-bea9d2e580fe7395Agalsidase beta (Fabrazyme®) and pegunigalsidase alfa-iwxj (Elfabrio) 08.00.69
7b233fad-4123-45d7-b468-7eab2fcbf43e.aspx
  
12.04.03dAirAmbulanceServices12.04.03dMiscellaneous (12)Air Ambulance Services7b233fad-4123-45d7-b468-7eab2fcbf43e7743Air Ambulance Services12.04.03
d0ddce51-9d5c-4475-aa85-9d248ec67ec5.aspx
  
08.01.22eAlemtuzumab(Lemtrada®)08.01.22ePharmacy (08)Alemtuzumab (Lemtrada®)d0ddce51-9d5c-4475-aa85-9d248ec67ec57703Alemtuzumab (Lemtrada®)08.01.22
e27cc682-844f-4d95-9c6e-693517f18fcf.aspx
  
08.00.72lAlglucosidasealfa(e.g.,Lumizyme®),Avalglucosidasealfa-ngpt(Nexviazyme®),Cipaglucosidasealfa-atga(Pombiliti™)08.00.72lPharmacy (08)Alglucosidase alfa (e.g., Lumizyme®), Avalglucosidase alfa-ngpt (Nexviazyme® ), Cipaglucosidase alfa-atga (Pombiliti™ )e27cc682-844f-4d95-9c6e-693517f18fcf7880Alglucosidase alfa (e.g., Lumizyme®), Avalglucosidase alfa-ngpt (Nexviazyme® ), Cipaglucosidase alfa-atga (Pombiliti™ )08.00.72
7cda42a8-62ee-45b1-837c-48fc772dba27.aspx
  
07.00.21kAllergyImmunotherapy07.00.21kMedicine (07)Allergy Immunotherapy7cda42a8-62ee-45b1-837c-48fc772dba277802Allergy Immunotherapy07.00.21
644adcb9-a1e6-4909-a24d-dedd58ff54a7.aspx
  
08.01.88bAllogeneicProcessedThymusTissue-agdc(Rethymic®)08.01.88bPharmacy (08)Allogeneic Processed Thymus Tissue-agdc (Rethymic®)644adcb9-a1e6-4909-a24d-dedd58ff54a77852Allogeneic Processed Thymus Tissue-agdc (Rethymic®)08.01.88
441bf6fa-8d20-4f99-a633-1df6e903aadb.aspx
  
06.02.29gAlloMap™MolecularExpressionTestingforHeartTransplantRejection(IndependenceAdministrators)06.02.29gPathology and Laboratory (06)AlloMap™ Molecular Expression Testing for Heart Transplant Rejection (Independence Administrators)441bf6fa-8d20-4f99-a633-1df6e903aadb7128AlloMap™ Molecular Expression Testing for Heart Transplant Rejection (Independence Administrators)06.02.29
9950282a-bf31-41df-bfa4-8ae278d5c070.aspx
  
08.00.91fAlpha-1AntitrypsinTherapy(e.g.,Prolastin-C®,AralastNP®,Glassia®,Zemaira®)08.00.91fPharmacy (08)Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C®, Aralast NP®, Glassia®, Zemaira®)9950282a-bf31-41df-bfa4-8ae278d5c0707440Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C®, Aralast NP®, Glassia®, Zemaira®)08.00.91
6e6273d3-b46b-40a3-aaf0-b57dd2a00a57.aspx
  
07.02.09kAmbulatoryBloodPressureMonitoring(ABPM)andHomeBloodPressureMonitoring(HBPM)Devices07.02.09kMedicine (07)Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) Devices6e6273d3-b46b-40a3-aaf0-b57dd2a00a577296Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) Devices07.02.09
8529f999-41e5-430a-b9ae-9ee780275022.aspx
  
07.02.21rAmbulatoryElectrocardiography(AECG)MonitoringandMobileCardiacOutpatientTelemetry(MCOT)Monitoring07.02.21rMedicine (07)Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring8529f999-41e5-430a-b9ae-9ee7802750227312Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring07.02.21
b214a3cf-cf92-4215-87b2-d85c51213e37.aspx
  
08.01.90bAmivantamab-vmjw(Rybrevant®)08.01.90bPharmacy (08)Amivantamab-vmjw (Rybrevant®)b214a3cf-cf92-4215-87b2-d85c51213e377528Amivantamab-vmjw (Rybrevant®)08.01.90
57afdac7-8eea-43a0-80f0-d92877a5f407.aspx
  
01.00.12dAnesthesiaServicesforEpidural,ParavertebralFacetandSacroiliacJointInjectionsforSpinalJointManagement01.00.12dAnesthesia (01)Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management57afdac7-8eea-43a0-80f0-d92877a5f4077735Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management01.00.12
{"7736": {"Id":7736,"MPAttachmentLetter":"A","Title":"ICD-10 Codes and Narratives","MPPolicyAttachmentInternalSourceId":9986,"PolicyAttachmentPageName":"6946ec31-d856-4210-86ac-9e32f5752aab"},}
a7c83b2a-33e3-49f0-97ab-7bf12119226d.aspx
  
08.01.82cAnifrolumab-fnia(Saphnelo®)08.01.82cPharmacy (08)Anifrolumab-fnia (Saphnelo®)a7c83b2a-33e3-49f0-97ab-7bf12119226d7383Anifrolumab-fnia (Saphnelo®)08.01.82
a8e06173-3cfe-4b4f-b0a6-32b7373bc5ef.aspx
  
05.00.39vAnkle-Foot/Knee-Ankle-FootOrthoses05.00.39vDME (05)Ankle-Foot/Knee-Ankle-Foot Orthosesa8e06173-3cfe-4b4f-b0a6-32b7373bc5ef7644Ankle-Foot/Knee-Ankle-Foot Orthoses05.00.39
{"7645": {"Id":7645,"MPAttachmentLetter":"A","Title":"HCPCS Codes","MPPolicyAttachmentInternalSourceId":10050,"PolicyAttachmentPageName":"1fdfcdb0-9ff8-4824-bc3f-559176745d26"},}
e7aec092-e2e2-4fca-b314-879881eace7e.aspx
  
06.03.04oApheresisTherapy06.03.04oPathology and Laboratory (06)Apheresis Therapye7aec092-e2e2-4fca-b314-879881eace7e7493Apheresis Therapy06.03.04
64b4c7d8-0095-4f37-a464-11ddf52d9cba.aspx
  
05.00.84Apos®biomechanicalshoesystem05.00.84DME (05)Apos® biomechanical shoe system64b4c7d8-0095-4f37-a464-11ddf52d9cba7940Apos® biomechanical shoe system05.00.84
b924d012-851d-4312-94e9-48fcebd87147.aspx
  
11.08.05gApplicationandRemovalofTattoos11.08.05gSurgery (11)Application and Removal of Tattoosb924d012-851d-4312-94e9-48fcebd871477665Application and Removal of Tattoos11.08.05
d805c027-d99b-4e5b-8127-41e3ced25613.aspx
  
14.00.03bAppliedBehaviorAnalysis(ABA)fortheTreatmentofAutismSpectrumDisorder(ASD)14.00.03bBehavioral Health (14)Applied Behavior Analysis (ABA) for the Treatment of Autism Spectrum Disorder (ASD)d805c027-d99b-4e5b-8127-41e3ced256137978Applied Behavior Analysis (ABA) for the Treatment of Autism Spectrum Disorder (ASD)14.00.03
ca6558bd-7c31-4e1d-b013-b5cb099bb5a2.aspx
  
11.05.16mAqueousShunts,Microstents,Viscocanalostomy,andCanaloplastyfortheTreatmentofGlaucoma11.05.16mSurgery (11)Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucomaca6558bd-7c31-4e1d-b013-b5cb099bb5a27650Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma11.05.16
{"7651": {"Id":7651,"MPAttachmentLetter":"A","Title":"ICD-10 codes","MPPolicyAttachmentInternalSourceId":9964,"PolicyAttachmentPageName":"0d1acaf1-fc56-4603-a14c-20cd8cab62c1"},}
731122a5-ce6b-4828-8fe1-ed08ddd7f8ee.aspx
  
11.14.19pArtificialIntervertebralCervicalDiscInsertion(IndependenceAdministrators)11.14.19pSurgery (11)Artificial Intervertebral Cervical Disc Insertion (Independence Administrators)731122a5-ce6b-4828-8fe1-ed08ddd7f8ee7348Artificial Intervertebral Cervical Disc Insertion (Independence Administrators)11.14.19
e94f72d3-f162-4d86-a218-fc65d6294bba.aspx
  
08.01.35kAsparaginaseErwiniaChrysanthemi(recombinant)-rywn(Rylaze®)08.01.35kPharmacy (08)Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze®)e94f72d3-f162-4d86-a218-fc65d6294bba8074Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze®)08.01.35
e81aedc0-6fee-4de8-bfe5-37273039c3b6.aspx
  
06.02.27pAssaysofGeneticExpressioninTumorTissueforBreastCancerPrognosis(IndependenceAdministrators)06.02.27pPathology and Laboratory (06)Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (Independence Administrators)e81aedc0-6fee-4de8-bfe5-37273039c3b67138Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (Independence Administrators)06.02.27
b753c112-cb1c-4a31-a437-b39ee728998e.aspx
  
07.10.06jAssistedReproductiveTechnologyforInfertilityandOocyteCryopreservation07.10.06jMedicine (07)Assisted Reproductive Technology for Infertility and Oocyte Cryopreservationb753c112-cb1c-4a31-a437-b39ee728998e6522Assisted Reproductive Technology for Infertility and Oocyte Cryopreservation07.10.06
43d23fe4-0f2f-4a17-819e-7d9032d19af1.aspx
  
08.01.69fAtezolizumab(Tecentriq®)andAtezolizumabwithHyaluronidase-tqjs(TecentriqHybreza™)08.01.69fPharmacy (08)Atezolizumab (Tecentriq®) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza™)43d23fe4-0f2f-4a17-819e-7d9032d19af17568Atezolizumab (Tecentriq®) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza™)08.01.69
7c1a340a-393c-4869-9862-1dba7104bd3f.aspx
  
08.02.24Atidarsageneautotemcel(Lenmeldy)08.02.24Pharmacy (08)Atidarsagene autotemcel (Lenmeldy)7c1a340a-393c-4869-9862-1dba7104bd3f7404Atidarsagene autotemcel (Lenmeldy)08.02.24
9251a32c-6a7e-4184-8589-160c9c7c7e8a.aspx
  
05.00.82AuricularProstheses05.00.82DME (05)Auricular Prostheses9251a32c-6a7e-4184-8589-160c9c7c7e8a7579Auricular Prostheses05.00.82
3bc5cc35-7f80-4494-84dd-eb645cad0fbc.aspx
  
11.14.06jAutologousChondrocyteImplantation(ACI)andOtherCell-basedTreatmentsofFocalArticularCartilageLesions(IndependenceAdministrators)11.14.06jSurgery (11)Autologous Chondrocyte Implantation (ACI) and Other Cell-based Treatments of Focal Articular Cartilage Lesions (Independence Administrators)3bc5cc35-7f80-4494-84dd-eb645cad0fbc7279Autologous Chondrocyte Implantation (ACI) and Other Cell-based Treatments of Focal Articular Cartilage Lesions (Independence Administrators)11.14.06
dd700951-87d5-4759-bb8e-af57f14e4a33.aspx
  
05.00.29oAutomaticExternalCardioverterDefibrillators(WearableandNonwearable)05.00.29oDME (05)Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)dd700951-87d5-4759-bb8e-af57f14e4a337232Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)05.00.29
{"7233": {"Id":7233,"MPAttachmentLetter":"B","Title":"ICD-10 codes used to represent the Nonwearable Automatic External Defibrillator (AED):","MPPolicyAttachmentInternalSourceId":9496,"PolicyAttachmentPageName":"2a12e22d-6c14-4428-89cd-6eadd3f170f8"},"7234": {"Id":7234,"MPAttachmentLetter":"A","Title":"ICD-10 Codes used to represent the Wearable Automatic External Defibrillator (AED):","MPPolicyAttachmentInternalSourceId":9497,"PolicyAttachmentPageName":"b34b8bf3-f2f0-4ead-b9b4-2e7bea974064"},}
77017542-a222-43a5-85ef-78e70d08c670.aspx
  
07.03.23hAutonomicNervousSystemTesting07.03.23hMedicine (07)Autonomic Nervous System Testing77017542-a222-43a5-85ef-78e70d08c6707420Autonomic Nervous System Testing07.03.23
daa39d63-ad21-4f2f-9707-5a304116216c.aspx
  
08.01.64eAvelumab(Bavencio®)08.01.64ePharmacy (08)Avelumab (Bavencio®)daa39d63-ad21-4f2f-9707-5a304116216c7970Avelumab (Bavencio®)08.01.64
075379e8-6fc4-49ad-adc3-5a47b579e7c2.aspx
  
08.02.34Axatilimab-csfr(Niktimvo™)forIntravenousUse08.02.34Pharmacy (08)Axatilimab-csfr (Niktimvo™) for Intravenous Use075379e8-6fc4-49ad-adc3-5a47b579e7c27536Axatilimab-csfr (Niktimvo™) for Intravenous Use08.02.34
06478bb4-9c20-4f00-abbb-6302983f60f0.aspx
  
11.16.06kBalloonCatheterDilationofSinusOstiaforTreatmentofChronicRhinosinusitisorRecurrentAcuteRhinosinusitis11.16.06kSurgery (11)Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute Rhinosinusitis06478bb4-9c20-4f00-abbb-6302983f60f07209Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute Rhinosinusitis11.16.06
02a351a0-93ae-45be-993a-09f7ae131c2c.aspx
  
11.03.02wBariatricSurgery11.03.02wSurgery (11)Bariatric Surgery02a351a0-93ae-45be-993a-09f7ae131c2c8049Bariatric Surgery11.03.02
{"8050": {"Id":8050,"MPAttachmentLetter":"A","Title":"Body Mass Index (BMI) Charts","MPPolicyAttachmentInternalSourceId":10223,"PolicyAttachmentPageName":"c05a83d8-4320-4420-b7b0-1a39c2b706a1"},"8051": {"Id":8051,"MPAttachmentLetter":"B","Title":"Tanner Staging System Criteria for Adolescents","MPPolicyAttachmentInternalSourceId":10224,"PolicyAttachmentPageName":"65d82304-0c5a-423f-a507-a7afc8e77e2f"},}
a2962066-3a82-48f8-8d61-bcff508dfd79.aspx
  
08.00.99eBelimumab(Benlysta®)forIntravenousUse08.00.99ePharmacy (08)Belimumab (Benlysta®) for Intravenous Usea2962066-3a82-48f8-8d61-bcff508dfd797401Belimumab (Benlysta®) for Intravenous Use08.00.99
a7873711-965e-488a-bbf2-7e39b7a29da0.aspx
  
08.02.10bBeremageneGeperpavec(Vyjuvek™)08.02.10bPharmacy (08)Beremagene Geperpavec (Vyjuvek™)a7873711-965e-488a-bbf2-7e39b7a29da07953Beremagene Geperpavec (Vyjuvek™)08.02.10
9bc3c0c4-11e7-429a-bc7c-7184504e0383.aspx
  
08.01.89aBetibeglogeneAutotemcel[Beti-Cel(ZYNTEGLO®)]08.01.89aPharmacy (08)Betibeglogene Autotemcel [Beti-Cel (ZYNTEGLO®)]9bc3c0c4-11e7-429a-bc7c-7184504e03837388Betibeglogene Autotemcel [Beti-Cel (ZYNTEGLO®)]08.01.89
4c40e1aa-056f-47ca-8021-77ef505b19de.aspx
  
08.00.66wBevacizumab(Avastin®)andRelatedBiosimilarsForOncologicUse08.00.66wPharmacy (08)Bevacizumab (Avastin®) and Related Biosimilars For Oncologic Use4c40e1aa-056f-47ca-8021-77ef505b19de7889Bevacizumab (Avastin®) and Related Biosimilars For Oncologic Use08.00.66
{"7890": {"Id":7890,"MPAttachmentLetter":"A","Title":"ICD 10 Diagnosis Codes","MPPolicyAttachmentInternalSourceId":10175,"PolicyAttachmentPageName":"71ba67b1-78cc-4fce-8347-b60e04c06d66"},}
e069f430-2fe4-4e37-ac33-c8400e544e9e.aspx
  
00.10.39rBillingforProfessionalOffice-BasedServicesPerformedinanOutpatientOffice-BasedSettingLocatedwithinaFacilityoronaFacilityCampus00.10.39rAdministrative (00)Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campuse069f430-2fe4-4e37-ac33-c8400e544e9e8088Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus00.10.39
{"8089": {"Id":8089,"MPAttachmentLetter":"A","Title":"Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus","MPPolicyAttachmentInternalSourceId":10318,"PolicyAttachmentPageName":"0d19fa2e-adc6-4c66-a2f5-9ba6cb8ef899"},}
21ae79a9-3406-47c5-bb6d-1fae80367998.aspx
  
00.10.38aBillingRequirementsforMultipleBirthsforProfessionalProviders00.10.38aAdministrative (00)Billing Requirements for Multiple Births for Professional Providers21ae79a9-3406-47c5-bb6d-1fae803679986302Billing Requirements for Multiple Births for Professional Providers00.10.38
{"6303": {"Id":6303,"MPAttachmentLetter":"C","Title":"CODING SCENARIOS FOR REPORTING HIGH-ORDER MULTIPLE (TRIPLETS, QUADRUPLETS, ETC) BIRTHS WHEN ROUTINE OBSTETRIC (GLOBAL MATERNITY/OBSTETRIC [OB]) CARE WAS PROVIDED","MPPolicyAttachmentInternalSourceId":8677,"PolicyAttachmentPageName":"eb66d5c6-6236-4d27-97a4-bcdd186ff868"},"6304": {"Id":6304,"MPAttachmentLetter":"A","Title":"MULTIPLE BIRTH CODING SCENARIOS FOR DELIVERY OF TWINS WHEN ROUTINE OBSTETRIC (GLOBALE MATERNITY/OBSTETRIC [OB]) CARE WAS PROVIDED","MPPolicyAttachmentInternalSourceId":8678,"PolicyAttachmentPageName":"d50dbf13-85a1-46a6-ba08-f3aa39e2c495"},"6305": {"Id":6305,"MPAttachmentLetter":"D","Title":"MULTIPLE BIRTH CODING SCENARIOS FOR DELIVERY OF HIGH-ORDER MULTIPLES WHEN ANTEPARTUM CARE IS NOT PROVIDED","MPPolicyAttachmentInternalSourceId":8679,"PolicyAttachmentPageName":"e4baa2eb-649c-4057-b59a-482ec93d4622"},"6306": {"Id":6306,"MPAttachmentLetter":"B","Title":"MULTIPLE BIRTH CODING SCENARIOS FOR DELIVERY OF TWINS WHEN ANETEPARTUM CARE IS NOT PROVIDED","MPPolicyAttachmentInternalSourceId":8680,"PolicyAttachmentPageName":"c6801920-f2e5-42bd-8e26-0f6161437f1b"},}
1e2a3057-e8ea-49ef-92d4-e4ffaed58dca.aspx
  
07.00.01nBiofeedbackTherapy07.00.01nMedicine (07)Biofeedback Therapy1e2a3057-e8ea-49ef-92d4-e4ffaed58dca7106Biofeedback Therapy07.00.01
424c1518-89b9-41f5-bf39-d9d68912216c.aspx
  
07.06.03cBioimpedancefortheDetectionofLymphedema07.06.03cMedicine (07)Bioimpedance for the Detection of Lymphedema424c1518-89b9-41f5-bf39-d9d68912216c7865Bioimpedance for the Detection of Lymphedema07.06.03
e4983116-4d2d-4290-a906-c86d4aacb7a1.aspx
  
08.01.21hBlinatumomab(Blincyto®)08.01.21hPharmacy (08)Blinatumomab (Blincyto®)e4983116-4d2d-4290-a906-c86d4aacb7a17803Blinatumomab (Blincyto®)08.01.21
f346f6aa-0fe6-4cd9-b1b9-4c287cc422a6.aspx
  
11.01.06jBone-Anchored(Osseointegrated)HearingAidsandImplantableMiddleEarHearingAids11.01.06jSurgery (11)Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aidsf346f6aa-0fe6-4cd9-b1b9-4c287cc422a67442Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids11.01.06
79aefb3c-3ec6-40d6-aad9-d2d9ddfd4c43.aspx
  
09.00.04oBoneMineralDensity(BMD)Testing09.00.04oRadiology (09)Bone Mineral Density (BMD) Testing79aefb3c-3ec6-40d6-aad9-d2d9ddfd4c437586Bone Mineral Density (BMD) Testing09.00.04
57abed33-4345-4efa-a450-b212da97090b.aspx
  
08.00.26aeBotulinumToxinAgents08.00.26aePharmacy (08)Botulinum Toxin Agents57abed33-4345-4efa-a450-b212da97090b7875Botulinum Toxin Agents08.00.26
{"7876": {"Id":7876,"MPAttachmentLetter":"A","Title":"ICD-10 Diagnosis Codes","MPPolicyAttachmentInternalSourceId":9954,"PolicyAttachmentPageName":"e4d7ca99-ff81-4ca3-9a71-5c24ef3cbb31"},}
d9928a9a-12d1-4e54-aca6-e890d3c21eb1.aspx
  
09.00.10aaBrachytherapyandAcceleratedWholeBreastIrradiationusingThree-DimensionalConformationRadiationTherapy09.00.10aaRadiology (09)Brachytherapy and Accelerated Whole Breast Irradiation using Three-Dimensional Conformation Radiation Therapyd9928a9a-12d1-4e54-aca6-e890d3c21eb18018Brachytherapy and Accelerated Whole Breast Irradiation using Three-Dimensional Conformation Radiation Therapy09.00.10
222e390d-15b6-43d4-8bfe-d4266be37961.aspx
  
05.00.76iBreastPumps05.00.76iDME (05)Breast Pumps222e390d-15b6-43d4-8bfe-d4266be379617611Breast Pumps05.00.76
37ef9a10-9048-41c4-8af1-12855707d685.aspx
  
08.01.13lBrentuximabVedotin(Adcetris®)08.01.13lPharmacy (08)Brentuximab Vedotin (Adcetris®)37ef9a10-9048-41c4-8af1-12855707d6857808Brentuximab Vedotin (Adcetris®)08.01.13
cea694d5-0c4a-4a47-9848-473275304abd.aspx
  
11.16.09BronchialValves11.16.09Surgery (11)Bronchial Valvescea694d5-0c4a-4a47-9848-473275304abd7122Bronchial Valves11.16.09
8f5ac327-b276-49db-8d46-3111d845589d.aspx
  
00.01.52zBundledProcedureCodes00.01.52zAdministrative (00)Bundled Procedure Codes8f5ac327-b276-49db-8d46-3111d845589d8096Bundled Procedure Codes00.01.52
{"8097": {"Id":8097,"MPAttachmentLetter":"B","Title":"Procedures/Services Not Eligible for Separate Reimbursement","MPPolicyAttachmentInternalSourceId":10320,"PolicyAttachmentPageName":"5124eb14-b8d3-4104-96c8-b818ff1d7422"},"8098": {"Id":8098,"MPAttachmentLetter":"A","Title":"Always Bundled and Bundled Procedures/Services (MPFSDB Indicators B and T)","MPPolicyAttachmentInternalSourceId":10321,"PolicyAttachmentPageName":"db84b66f-20be-4e4e-a23d-006df1d6c25d"},"8099": {"Id":8099,"MPAttachmentLetter":"D","Title":"Procedures/Services Not Eligible for Separate Reimbursement​ when reported with another specific Procedure/Service​","MPPolicyAttachmentInternalSourceId":10322,"PolicyAttachmentPageName":"388327aa-2dec-4700-a890-084f2314c28e"},"8100": {"Id":8100,"MPAttachmentLetter":"C","Title":"Procedures/Services Not Eligible for Reimbursement","MPPolicyAttachmentInternalSourceId":10323,"PolicyAttachmentPageName":"59b28bb4-c162-4926-af77-83d80c55cc6a"},}
1dd3bb1d-ed2c-411e-944c-598aa3293099.aspx
  
08.01.49bBurosumab-twza(Crysvita®)08.01.49bPharmacy (08)Burosumab-twza (Crysvita®)1dd3bb1d-ed2c-411e-944c-598aa32930997392Burosumab-twza (Crysvita®)08.01.49
2a8f5809-51b6-44d2-8610-4a8c58c134d2.aspx
  
08.01.51cCanakinumab(Ilaris®)08.01.51cPharmacy (08)Canakinumab (Ilaris®)2a8f5809-51b6-44d2-8610-4a8c58c134d27380Canakinumab (Ilaris®)08.01.51
{"7381": {"Id":7381,"MPAttachmentLetter":"A","Title":"ICD-10 Codes and Narratives","MPPolicyAttachmentInternalSourceId":9689,"PolicyAttachmentPageName":"cb8ad03a-ddc0-41a3-8712-f39688fb6dde"},}
8af288c7-5ed3-48e7-89a3-f3c180c0e9bd.aspx
  
10.01.01rCardiacRehabilitation(CR)andIntensiveCardiacRehabilitation(ICR)Programs10.01.01rRehabilitation Services (10)Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs8af288c7-5ed3-48e7-89a3-f3c180c0e9bd7107Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs10.01.01
{"7108": {"Id":7108,"MPAttachmentLetter":"A","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":9418,"PolicyAttachmentPageName":"7a889d8c-2334-4e54-88cb-a49fbe7581f3"},}
8d3961de-2250-4ec2-8bba-c3aa909590f0.aspx
  
00.01.59pCareManagementandCarePlanningServices00.01.59pAdministrative (00)Care Management and Care Planning Services8d3961de-2250-4ec2-8bba-c3aa909590f08094Care Management and Care Planning Services00.01.59
8ba40715-bd89-4a76-a29e-191289963ed8.aspx
  
08.01.05mCarfilzomib(Kyprolis®)08.01.05mPharmacy (08)Carfilzomib (Kyprolis®)8ba40715-bd89-4a76-a29e-191289963ed87863Carfilzomib (Kyprolis®)08.01.05
e907f139-3ad4-48f3-aedf-59c8cb22a2ec.aspx
  
08.02.14aCasgevy™(exagamglogeneautotemcel)08.02.14aPharmacy (08)Casgevy™ (exagamglogene autotemcel)e907f139-3ad4-48f3-aedf-59c8cb22a2ec7962Casgevy™ (exagamglogene autotemcel)08.02.14
f52f2efa-c59c-42e0-81cd-e6bf24c6cd3e.aspx
  
00.10.15dCastandSplintApplicationsandAssociatedSupplies00.10.15dAdministrative (00)Cast and Splint Applications and Associated Suppliesf52f2efa-c59c-42e0-81cd-e6bf24c6cd3e6629Cast and Splint Applications and Associated Supplies00.10.15
{"6630": {"Id":6630,"MPAttachmentLetter":"A","Title":"Procedure Codes Related to Cast and Splint Applications and Associated Supplies","MPPolicyAttachmentInternalSourceId":8996,"PolicyAttachmentPageName":"fd33be68-8e44-4b85-992e-1da428d46692"},}
b15906e4-661b-412b-bd63-5e77ad3db24d.aspx
  
11.01.07gCataractSurgery11.01.07gSurgery (11)Cataract Surgeryb15906e4-661b-412b-bd63-5e77ad3db24d7935Cataract Surgery11.01.07
{"7936": {"Id":7936,"MPAttachmentLetter":"A","Title":"ICD 10 codes for Cataract Surgery","MPPolicyAttachmentInternalSourceId":10188,"PolicyAttachmentPageName":"89fce395-c973-449f-a958-cdc7e4b4fef3"},}
0eb91e13-b77e-4684-9966-a46b09b62e90.aspx
  
11.02.06rCatheterAblationofCardiacArrhythmias11.02.06rSurgery (11)Catheter Ablation of Cardiac Arrhythmias0eb91e13-b77e-4684-9966-a46b09b62e907585Catheter Ablation of Cardiac Arrhythmias11.02.06
a308ffe0-dbc7-4989-a4a3-c4c6e5a50550.aspx
  
08.01.66eCemiplimab-rwlc(Libtayo®)08.01.66ePharmacy (08)Cemiplimab-rwlc (Libtayo®)a308ffe0-dbc7-4989-a4a3-c4c6e5a505507997Cemiplimab-rwlc (Libtayo®)08.01.66
ad7c08b2-fec8-4bae-b8be-e954714f2fff.aspx
  
08.01.39dCerliponasealfa(Brineura®)08.01.39dPharmacy (08)Cerliponase alfa (Brineura®)ad7c08b2-fec8-4bae-b8be-e954714f2fff7942Cerliponase alfa (Brineura®)08.01.39
{"7943": {"Id":7943,"MPAttachmentLetter":"A","Title":"Dosing and Frequency Requirements for Cerliponase alfa (Brineura®)","MPPolicyAttachmentInternalSourceId":10163,"PolicyAttachmentPageName":"abfbbd59-bf41-4f35-94a5-fe2224d5a749"},}
3891bd5e-ea12-495a-ac3e-b56da52581cc.aspx
  
05.00.61hCervicalTractionDevicesforIn-homeUse05.00.61hDME (05)Cervical Traction Devices for In-home Use3891bd5e-ea12-495a-ac3e-b56da52581cc7941Cervical Traction Devices for In-home Use05.00.61
5b8d2b26-ab82-42ab-a083-a97b77cc3ef9.aspx
  
08.00.67oCetuximab(Erbitux®)08.00.67oPharmacy (08)Cetuximab (Erbitux®)5b8d2b26-ab82-42ab-a083-a97b77cc3ef97813Cetuximab (Erbitux®)08.00.67
{"7814": {"Id":7814,"MPAttachmentLetter":"B","Title":"ICD-10 Codes for Cetuximab (Erbitux®)","MPPolicyAttachmentInternalSourceId":9909,"PolicyAttachmentPageName":"2a0874dc-df4b-4563-bb51-2dbbd9e3e83d"},"7815": {"Id":7815,"MPAttachmentLetter":"A","Title":"Dosing and Frequency Requirements","MPPolicyAttachmentInternalSourceId":9910,"PolicyAttachmentPageName":"d8138daf-8717-4154-8537-1061f142bf7c"},}
d4f8afbb-d3f0-422f-98c4-28270c126982.aspx
  
11.08.08hChemicalPeels11.08.08hSurgery (11)Chemical Peelsd4f8afbb-d3f0-422f-98c4-28270c1269827923Chemical Peels11.08.08
e2eeb898-d3b9-41c6-ad2e-eb54fe92f53f.aspx
  
08.01.43qChimericAntigenReceptor(CART)Therapy:YescartaTecartus,Breyanzi,KymriahandAucatzyl08.01.43qPharmacy (08)Chimeric Antigen Receptor (CART) Therapy: Yescarta Tecartus, Breyanzi, Kymriah and Aucatzyle2eeb898-d3b9-41c6-ad2e-eb54fe92f53f8145Chimeric Antigen Receptor (CART) Therapy: Yescarta Tecartus, Breyanzi, Kymriah and Aucatzyl08.01.43
5e4993b3-068e-4435-b4d9-2bb95be12d00.aspx
  
08.02.50ChimericAntigenReceptorTherapy(CART):Carvykti®&Abecma®​08.02.50Pharmacy (08)Chimeric Antigen Receptor Therapy (CART): Carvykti® & Abecma®​5e4993b3-068e-4435-b4d9-2bb95be12d008144Chimeric Antigen Receptor Therapy (CART): Carvykti® & Abecma®​08.02.50
6e45bb76-1fb9-473c-8474-da097917824e.aspx
  
10.02.02kChiropracticSpinalandExtraspinalManipulationTherapy10.02.02kRehabilitation Services (10)Chiropractic Spinal and Extraspinal Manipulation Therapy6e45bb76-1fb9-473c-8474-da097917824e7556Chiropractic Spinal and Extraspinal Manipulation Therapy10.02.02
24204b74-ba2c-4230-8fbc-5bcec1799125.aspx
  
08.00.92akCoagulationFactors08.00.92akPharmacy (08)Coagulation Factors24204b74-ba2c-4230-8fbc-5bcec17991258058Coagulation Factors08.00.92
e249ba41-d0da-4d92-a4ba-3a9c77d1a6da.aspx
  
06.02.54dCobalamin(VitaminB12),FolicAcid,andHomocysteineTesting06.02.54dPathology and Laboratory (06)Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testinge249ba41-d0da-4d92-a4ba-3a9c77d1a6da7963Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing06.02.54
{"7964": {"Id":7964,"MPAttachmentLetter":"A","Title":"MEDICALLY NECESSARY ICD 10 CODES FOR COBALAMIN (VITAMIN B12) AND/OR FOLIC ACID TESTING (CPT CODES 82607, 82608, 82746, AND 82747)","MPPolicyAttachmentInternalSourceId":10212,"PolicyAttachmentPageName":"5481ae29-f42b-4005-ac80-fd4007662387"},}
e9c54fee-93ad-498d-9aa2-b73f0adc6d84.aspx
  
11.01.02sCochlearImplantation11.01.02sSurgery (11)Cochlear Implantatione9c54fee-93ad-498d-9aa2-b73f0adc6d847592Cochlear Implantation11.01.02
ff95cd40-d1da-42e8-9af6-5575bdea91a5.aspx
  
08.01.71Collagenaseclostridiumhistolyticum(Xiaflex®),collagenaseclostridiumhistolyticum-aaes(Qwo®)08.01.71Pharmacy (08)Collagenase clostridium histolyticum (Xiaflex ®), collagenase clostridium histolyticum-aaes (Qwo®)ff95cd40-d1da-42e8-9af6-5575bdea91a57399Collagenase clostridium histolyticum (Xiaflex ®), collagenase clostridium histolyticum-aaes (Qwo®)08.01.71
35329384-4ff5-4f27-b677-d2cb35b726d8.aspx
  
11.03.12vColorectalCancerScreening11.03.12vSurgery (11)Colorectal Cancer Screening35329384-4ff5-4f27-b677-d2cb35b726d87443Colorectal Cancer Screening11.03.12
bd65e1a4-f2f6-4bee-92f1-e5ace6a688d6.aspx
  
12.00.03hComplementaryandIntegrativeHealthServices12.00.03hMiscellaneous (12)Complementary and Integrative Health Servicesbd65e1a4-f2f6-4bee-92f1-e5ace6a688d66308Complementary and Integrative Health Services12.00.03
f260f99f-caf1-4e5e-8f7f-7577cfb2977d.aspx
  
11.14.30CompositeTissueAllotransplantationoftheHand(s)andFace11.14.30Surgery (11)Composite Tissue Allotransplantation of the Hand(s) and Facef260f99f-caf1-4e5e-8f7f-7577cfb2977d7548Composite Tissue Allotransplantation of the Hand(s) and Face11.14.30
d2119750-381b-413e-a14f-c6b03d6c4d86.aspx
  
05.00.37jCompressionGarments05.00.37jDME (05)Compression Garmentsd2119750-381b-413e-a14f-c6b03d6c4d867265Compression Garments05.00.37
cb0fc153-8986-46d9-8e4a-14cf4dcb7be1.aspx
  
09.00.42dComputer-AidedDetection(CAD)SystemforUsewithChestRadiographs09.00.42dRadiology (09)Computer-Aided Detection (CAD) System for Use with Chest Radiographscb0fc153-8986-46d9-8e4a-14cf4dcb7be17818Computer-Aided Detection (CAD) System for Use with Chest Radiographs09.00.42
ad6a609f-0015-4e5f-94d3-793aa8cda385.aspx
  
11.14.17eComputer-assistedMusculoskeletalSurgicalNavigationalOrthopedicProcedure11.14.17eSurgery (11)Computer-assisted Musculoskeletal Surgical Navigational Orthopedic Proceduread6a609f-0015-4e5f-94d3-793aa8cda3857491Computer-assisted Musculoskeletal Surgical Navigational Orthopedic Procedure11.14.17
6b345f32-5fc3-4d8f-b455-be8e91900cb5.aspx
  
00.01.69bConsultationServices00.01.69bAdministrative (00)Consultation Services6b345f32-5fc3-4d8f-b455-be8e91900cb56315Consultation Services00.01.69
767990f8-2172-42dc-85f6-3f31d84617c5.aspx
  
07.13.11kContactLensesfortheTreatmentofPersistent(Corneal)EpithelialDefects07.13.11kMedicine (07)Contact Lenses for the Treatment of Persistent (Corneal) Epithelial Defects767990f8-2172-42dc-85f6-3f31d84617c57928Contact Lenses for the Treatment of Persistent (Corneal) Epithelial Defects07.13.11
{"7929": {"Id":7929,"MPAttachmentLetter":"A","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":10160,"PolicyAttachmentPageName":"ef01ac40-6c2b-49ed-a843-80b758b45d7c"},}
d7def89b-2c58-49c2-b6c4-4281d66bb663.aspx
  
09.00.11eContrastAgentsUsedinConjunctionwithEchocardiography09.00.11eRadiology (09)Contrast Agents Used in Conjunction with Echocardiographyd7def89b-2c58-49c2-b6c4-4281d66bb6637136Contrast Agents Used in Conjunction with Echocardiography09.00.11
98eaad96-491e-41a7-904f-6233d4e260b8.aspx
  
07.13.07mCornealPachymetryUsingUltrasound07.13.07mMedicine (07)Corneal Pachymetry Using Ultrasound98eaad96-491e-41a7-904f-6233d4e260b87724Corneal Pachymetry Using Ultrasound07.13.07
{"7725": {"Id":7725,"MPAttachmentLetter":"A","Title":"ICD-10-CM codes","MPPolicyAttachmentInternalSourceId":9933,"PolicyAttachmentPageName":"e1b32744-9092-43ea-a983-f1946f934338"},}
5afefb9d-41ca-4003-a3e8-6baa17d41303.aspx
  
09.00.58aCoronaryArteryCalcium(CAC)TestingUsingComputedTomography(IndependenceAdministrators)09.00.58aRadiology (09)Coronary Artery Calcium (CAC) Testing Using Computed Tomography (Independence Administrators)5afefb9d-41ca-4003-a3e8-6baa17d413037668Coronary Artery Calcium (CAC) Testing Using Computed Tomography (Independence Administrators)09.00.58
409dad71-92c1-4251-9e7c-ff95518bc57a.aspx
  
08.02.40Cosibelimab-ipdl(Unloxcyt™)08.02.40Pharmacy (08)Cosibelimab-ipdl (Unloxcyt™)409dad71-92c1-4251-9e7c-ff95518bc57a7539Cosibelimab-ipdl (Unloxcyt™)08.02.40
db363d81-2a6f-410c-93a0-2683359b4855.aspx
  
12.01.03bCosmeticProcedures12.01.03bMiscellaneous (12)Cosmetic Proceduresdb363d81-2a6f-410c-93a0-2683359b48557051Cosmetic Procedures12.01.03
7dc5715f-29f3-4efd-bb5c-4903d6859d58.aspx
  
08.01.08vCoverageofAnticancerPrescriptionOralandInjectableDrugsandBiologicsandSupportiveAgents08.01.08vPharmacy (08)Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents7dc5715f-29f3-4efd-bb5c-4903d6859d588109Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents08.01.08
{}
aa807c48-d1a3-4b18-bad0-2b8f3e3f8dc0.aspx
  
05.00.04eCoverageofMedicalDevices05.00.04eDME (05)Coverage of Medical Devicesaa807c48-d1a3-4b18-bad0-2b8f3e3f8dc06825Coverage of Medical Devices05.00.04
c8c2eca5-8b8c-441a-b499-535004b1ba4c.aspx
  
05.00.80dCranialElectrotherapyStimulation05.00.80dDME (05)Cranial Electrotherapy Stimulationc8c2eca5-8b8c-441a-b499-535004b1ba4c7949Cranial Electrotherapy Stimulation05.00.80
010d9d1d-ca78-440f-92f2-e9aacbb31b28.aspx
  
05.00.25kCranialRemoldingOrthoses(Helmets)05.00.25kDME (05)Cranial Remolding Orthoses (Helmets)010d9d1d-ca78-440f-92f2-e9aacbb31b287608Cranial Remolding Orthoses (Helmets)05.00.25
6220d0b9-e373-4ac9-b761-560ded87f65d.aspx
  
08.00.04bcrizanlizumab-tmca(Adakveo®)08.00.04bPharmacy (08)crizanlizumab-tmca (Adakveo®)6220d0b9-e373-4ac9-b761-560ded87f65d7533crizanlizumab-tmca (Adakveo®)08.00.04
517430e0-ffcc-4d31-bb76-4a91810f5c4e.aspx
  
08.02.31Crovalimab-akkz(Piasky)08.02.31Pharmacy (08)Crovalimab-akkz (Piasky)517430e0-ffcc-4d31-bb76-4a91810f5c4e7361Crovalimab-akkz (Piasky)08.02.31
c6d32192-789c-4c89-a04e-7a0100e50071.aspx
  
11.11.03dCryosurgicalAblationoftheProstateGland11.11.03dSurgery (11)Cryosurgical Ablation of the Prostate Glandc6d32192-789c-4c89-a04e-7a0100e500718115Cryosurgical Ablation of the Prostate Gland11.11.03
bfb27619-c90c-4f26-8dd4-bc8909018d9b.aspx
  
08.01.29mDaratumumab(Darzalex®),DaratumumabandHyaluronidase-fihj(DarzalexFaspro®)08.01.29mPharmacy (08)Daratumumab (Darzalex®), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro®)bfb27619-c90c-4f26-8dd4-bc8909018d9b7604Daratumumab (Darzalex®), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro®)08.01.29
1 - 100Next
Connect with Us

2026 Independence Blue Cross

Independence Blue Cross is a subsidiary of Independence Health Group, Inc. — independent licensees of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.